drug prices drug prices
Stories About

drug prices

Activists protest the prices of prescription drug outside the Department of Health and Human Services in Washington, D.C., in October 2022. Anna Moneymaker/Getty Images hide caption

toggle caption
Anna Moneymaker/Getty Images

Chairman of the Senate Health, Education, Labor and Pensions Committee Sen. Bernie Sanders, a Vermont Independent, questions Dr. Monica Bertagnolli during her confirmation hearing to become director of the National Institutes of Health. Kevin Dietsch/Getty Images hide caption

toggle caption
Kevin Dietsch/Getty Images

Sen. Sanders pushes NIH to rein in drug prices

  • Download
  • <iframe src="https://www.npr.org/player/embed/1213612489/1213684527" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

President Joe Biden and Vice President Kamala Harris at the White House event on August 29 where they announced the list of the first 10 medicines targeted for Medicare negotiations. Win McNamee/Getty Images hide caption

toggle caption
Win McNamee/Getty Images

Pharmacy benefit managers are middlemen who work with drug companies and insurers, helping set the retail prices for prescription drugs Americans rely on for their health. They're now the subject of a number of new bills in Congress. Robert F. Bukaty/AP hide caption

toggle caption
Robert F. Bukaty/AP

WASHINGTON, DC - OCTOBER 06: Activists hit a piñata carrying empty pill bottles during a protest against the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) building on October 06, 2022 in Washington, DC. (Photo by Anna Moneymaker/Getty Images) Anna Moneymaker/Getty Images hide caption

toggle caption
Anna Moneymaker/Getty Images

This April 24, 2008, file photo shows the former North American headquarters of Novo Nordisk Inc., in Plainsboro, N.J. The Danish drugmaker will start slashing some U.S. insulin prices up to 75% next year, following a path set earlier this month by rival Eli Lilly. Mel Evans/AP hide caption

toggle caption
Mel Evans/AP

President Biden speaks during an event Tuesday celebrating the passage of the Inflation Reduction Act on the South Lawn of the White House. The new law gives Medicare the power to negotiate drug prices. Anna Moneymaker/Getty Images hide caption

toggle caption
Anna Moneymaker/Getty Images
Drew Angerer/Getty Images

Drugs, electric cars, taxes

  • Download
  • <iframe src="https://www.npr.org/player/embed/1114627168/1198988542" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

A hormone-blocking drug implant was prescribed for an active 8-year-old girl diagnosed with central precocious puberty. The price of one option was thousands of dollars less than the other. Kristina Barker for KHN hide caption

toggle caption
Kristina Barker for KHN

Drugmaker drops cheaper version of drug, leaving patients stuck with pricier one

  • Download
  • <iframe src="https://www.npr.org/player/embed/1051878026/1053528002" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Canadian Minister of Health Patty Hajdu, pictured in 2016, announced a new rule in response to a U.S. plan to import drugs from Canada. Charly Triballeau/AFP via Getty Images hide caption

toggle caption
Charly Triballeau/AFP via Getty Images

Remdesivir, an experimental antiviral drug made by Gilead Sciences, has been authorized by the Food and Drug Administration for emergency use in treating severely ill COVID-19 patients. Ulrich Perry/POOL/AFP via Getty Images hide caption

toggle caption
Ulrich Perry/POOL/AFP via Getty Images

Putting A Price On COVID-19 Treatment Remdesivir

  • Download
  • <iframe src="https://www.npr.org/player/embed/851632704/853467108" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

President Trump's State of the Union address laid bare his bitter partisan standoff with Democrats and left little doubt that legislative accomplishments between now and the election will be difficult. Mandel Ngan/AFP via Getty Images hide caption

toggle caption
Mandel Ngan/AFP via Getty Images

Martin Shkreli, former CEO of Turing Pharmaceuticals, appeared before the House Oversight Committee during a contentious hearing on drug pricing on Feb. 4, 2016. Mark Wilson/Getty Images hide caption

toggle caption
Mark Wilson/Getty Images

The House voted to pass Speaker Nancy Pelosi's prescription drug bill. The plan proposes, among other things, allowing Medicare to negotiate prices with drugmakers for some drugs. Drew Angerer/Getty Images hide caption

toggle caption
Drew Angerer/Getty Images

The House Passed Its Prescription Drug Plan — Here's What's In It

  • <iframe src="https://www.npr.org/player/embed/787190604/787420086" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Secretary of Health and Human Services Alex Azar announced his agency is dropping a proposal intended to lower drug prices. Michael Brochstein/SOPA Images/LightRocket via Getty Images hide caption

toggle caption
Michael Brochstein/SOPA Images/LightRocket via Getty Images

Dr. Rebekah Gee, secretary of the Louisiana Department of Health, negotiated a deal with a drugmaker to get the state a better price for expensive hepatitis C medications for its Medicaid and prison populations. Tom Williams/CQ-Roll Call Inc. hide caption

toggle caption
Tom Williams/CQ-Roll Call Inc.

Alex Azar, secretary of Health and Human Services, announced a new rule requiring drugmakers to publish drug list prices in TV ads. Al Drago/Bloomberg via Getty Images hide caption

toggle caption
Al Drago/Bloomberg via Getty Images